➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Mallinckrodt
Baxter
Medtronic
Express Scripts

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 8,449,470

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,449,470
Title:System for repetitive measurements of cardiac output in freely moving individuals
Abstract: A system for evaluating the cardiovascular system parameters using indicator dilution and non-invasive or minimally invasive detection and calibration methods are disclosed. Intravascular indicators are stimulated, and emissions patterns detected for computation of cardiac output, cardiac index, blood volume and other indicators of cardiovascular health.
Inventor(s): Blanco; Cesar (Los Angeles, CA), Richmond; Frances (South Pasadena, CA), Holschneider; Daniel P. (Los Angeles, CA), Maarek; Jean-Michel I. (Rancho Palos Verdes, CA)
Assignee: Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California (Los Angeles, CA) N/A (N/A)
Application Number:12/544,957
Patent Claims:see list of patent claims

Details for Patent 8,449,470

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California (Los Angeles, CA) N/A (N/A) 2022-05-21 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California (Los Angeles, CA) N/A (N/A) 2022-05-21 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Merck
Harvard Business School
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.